FERRI, NICOLA

FERRI, NICOLA  

Dipartimento di Medicina - DIMED  

Mostra records
Risultati 1 - 20 di 216 (tempo di esecuzione: 0.038 secondi).
Titolo Data di pubblicazione Autori Rivista Serie Titolo libro
17-AAG increases autophagic removal of mutant androgen receptor in spinal and bulbar muscular atrophy 2011 FERRI, NICOLA + NEUROBIOLOGY OF DISEASE - -
2-Amino-3-(phenylsulfanyl)norbornane-2-carboxylate: An Appealing Scaffold for the Design of Rac1-Tiam1 Protein-Protein Interaction Inhibitors 2014 FERRI, NICOLA + JOURNAL OF MEDICINAL CHEMISTRY - -
3-Aryl-N-aminoylsulfonylphenyl-1H-pyrazole-5-carboxamides : a new class of selective Rac inhibitors 2013 FERRI, NICOLASTRAGLIOTTO, STEFANO + MEDCHEMCOMM - -
A field-based disparity analysis of new 1,2,5-oxadiazole derivatives endowed with antiproliferative activity 2017 FERRI, NICOLA + CHEMICAL BIOLOGY & DRUG DESIGN - -
A Nutraceutical Formulation Containing Brown Algae Reduces Hepatic Lipid Accumulation by Modulating Lipid Metabolism and Inflammation in Experimental Models of NAFLD and NASH 2022 Gabbia, DanielaRoverso, MarcoZanotto, IlariaColognesi, MartinaSayaf, KatiaSarcognato, SamanthaArcidiacono, DilettaZaramella, AliceFerri, NicolaGuido, MariaRusso, Francesco PaoloBogialli, SaraCarrara, MariaDe Martin, Sara + MARINE DRUGS - -
A selective alpha1D-adrenoreceptor antagonist inhibits human prostate cancer cell proliferation and motility "in vitro" 2016 FERRI, NICOLA + PHARMACOLOGICAL RESEARCH - -
Ability of simvastatin to inhibit DNA synthesis in PDGF-BB-, EGF-, LPA- and ET-1- stimulated smooth muscle cells. 1997 FERRI, NICOLA + ATHEROSCLEROSIS - atherosclerosis
Ability of simvastatin to inhibit DNA synthesis of PDGF-BB-, EGF-, and LPA-stimulated smooth muscle cells. 1997 FERRI, NICOLA + ATHEROSCLEROSIS - atherosclerosis
Adipose tissue related adipokines and cytokines regulate PCSK9 expression in HepG2 cells 2016 FERRI, NICOLA + - - Medicina di Precisione - Medicina Traslazionale - Medicina di Laboratorio
Ajoene, a garlic compound, inhibits protein prenylation and arterial smooth muscle cell proliferation 2003 FERRI, NICOLA + BRITISH JOURNAL OF PHARMACOLOGY - -
Aliskiren inhibits prorenin-induced human aortic smooth muscle cell migration 2015 FERRI, NICOLA + JRAAS - -
Aliskiren reduces prorenin receptor expression and activity in cultured human aortic smooth muscle cells 2011 FERRI, NICOLA + JRAAS - -
AMP-activated protein kinase and the control of smooth muscle cell hyperproliferation in vascular disease 2012 FERRI, NICOLA VASCULAR PHARMACOLOGY - -
An in vivo active 1,2,5-oxadiazole Pt(II) complex: A promising anticancer agent endowed with STAT3 inhibitory properties 2017 FERRI, NICOLAGANDIN, VALENTINAMARZANO, CRISTINA + EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY - -
An NF-kappaB-dependent transcriptional program is required for collagen remodeling by human smooth muscle cells 2003 FERRI, NICOLA + THE JOURNAL OF BIOLOGICAL CHEMISTRY - -
Angiopoietin-Like 3 (ANGPTL3) and Atherosclerosis: Lipid and Non-Lipid Related Effects 2018 Lupo, Maria GiovannaFerri, Nicola JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE - -
Angiopoietin-like 3 and subclinical peripheral arterial disease: Evidence from the Brisighella Heart Study 2019 Ferri, Nicola + EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY - -
Antiatherosclerotic activities of mibefradil in cell culture 1997 FERRI, NICOLA + ATHEROSCLEROSIS - atherosclerosis
Antihypertensive treatment with calcium channel blockers and renal protection: focus on lercanidipine and lercanidipine/enalapril 2022 Ferri N. + EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES - -
Antiproliferative effects on human tumor cells and rat aortic smooth muscular cells of 2,3-heteroarylmaleimides and heterofused imides 2008 FERRI, NICOLA + BIOORGANIC & MEDICINAL CHEMISTRY - -